X-69957121-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM1BP4_StrongBP6BS2
The ENST00000374552.9(EDA):āc.491A>Cā(p.Glu164Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000755 in 1,205,355 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 30 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.000089 ( 0 hom., 4 hem., cov: 22)
Exomes š: 0.000074 ( 0 hom. 26 hem. )
Consequence
EDA
ENST00000374552.9 missense
ENST00000374552.9 missense
Scores
1
8
8
Clinical Significance
Conservation
PhyloP100: 5.17
Genes affected
EDA (HGNC:3157): (ectodysplasin A) The protein encoded by this gene is a type II membrane protein that can be cleaved by furin to produce a secreted form. The encoded protein, which belongs to the tumor necrosis factor family, acts as a homotrimer and may be involved in cell-cell signaling during the development of ectodermal organs. Defects in this gene are a cause of ectodermal dysplasia, anhidrotic, which is also known as X-linked hypohidrotic ectodermal dysplasia. Several transcript variants encoding many different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 2 uncertain in ENST00000374552.9
BP4
Computational evidence support a benign effect (MetaRNN=0.030016154).
BP6
Variant X-69957121-A-C is Benign according to our data. Variant chrX-69957121-A-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 44195.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=2}. Variant chrX-69957121-A-C is described in Lovd as [Likely_benign].
BS2
High Hemizygotes in GnomAd4 at 4 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EDA | NM_001399.5 | c.491A>C | p.Glu164Ala | missense_variant | 2/8 | ENST00000374552.9 | NP_001390.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EDA | ENST00000374552.9 | c.491A>C | p.Glu164Ala | missense_variant | 2/8 | 1 | NM_001399.5 | ENSP00000363680 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000975 AC: 11AN: 112809Hom.: 0 Cov.: 22 AF XY: 0.000143 AC XY: 5AN XY: 34955
GnomAD3 genomes
AF:
AC:
11
AN:
112809
Hom.:
Cov.:
22
AF XY:
AC XY:
5
AN XY:
34955
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000302 AC: 55AN: 182320Hom.: 0 AF XY: 0.000269 AC XY: 18AN XY: 66904
GnomAD3 exomes
AF:
AC:
55
AN:
182320
Hom.:
AF XY:
AC XY:
18
AN XY:
66904
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000741 AC: 81AN: 1092493Hom.: 0 Cov.: 28 AF XY: 0.0000726 AC XY: 26AN XY: 357921
GnomAD4 exome
AF:
AC:
81
AN:
1092493
Hom.:
Cov.:
28
AF XY:
AC XY:
26
AN XY:
357921
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000886 AC: 10AN: 112862Hom.: 0 Cov.: 22 AF XY: 0.000114 AC XY: 4AN XY: 35018
GnomAD4 genome
AF:
AC:
10
AN:
112862
Hom.:
Cov.:
22
AF XY:
AC XY:
4
AN XY:
35018
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
18
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Hypohidrotic X-linked ectodermal dysplasia Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 24, 2012 | Variant classified as Uncertain Significance - Favor Pathogenic. The Glu164Ala v ariant in EDA has been reported in one Chinese female with features of hypohidro tic ectodermal dysplasia and her mother and was absent from 150 control X chromo somes (Fan 2008). Although additional data is needed to determine the clinical s ignificance of this variant, we would lean towards a more likely pathogenic role for this variant. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;T;.;.;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
N;N;N;.;.
MutationTaster
Benign
N;N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;.
REVEL
Uncertain
Sift
Uncertain
D;.;.;D;.
Sift4G
Benign
T;T;T;T;T
Polyphen
P;P;P;.;.
Vest4
MutPred
Gain of glycosylation at S162 (P = 0.0582);Gain of glycosylation at S162 (P = 0.0582);Gain of glycosylation at S162 (P = 0.0582);.;.;
MVP
MPC
0.83
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at